NEUROCRINE BIOSCIENCES INC | Collaboration Agreements | Business Contracts

Collaboration and License Agreement dated November 22, 2021 between Heptares Therapeutics Limited and the Company (Filed With SEC on February 11, 2022)

First Amendment to Collaboration and License Agreement Dated August 31, 2011 between the Company and Abbott International Luxembourg S.a.r.l (Filed With SEC on May 5, 2021)

Collaboration Agreement dated June 15, 2010, by and between Abbott International Luxembourg S.a.r.l. and the Company as amended on August 31, 2011 (Filed With SEC on May 5, 2021)

Collaboration and License Agreement dated March 31, 2015 between Mitsubishi Tanabe Pharma Corporation and the Company (Filed With SEC on May 5, 2021)

Amendment No. 1 to Collaboration and License Agreement dated June 14, 2019 between Voyager Therapeutics, Inc. and the Company (Filed With SEC on July 29, 2019)

NEUROCRINE BIOSCIENCES INC (18) | Collaboration Agreements (5)